Evidence map›Paper›PMID 42200832›Full record

ArticleAntibodies (Basel, Switzerland)2026

The Shifting Core: Antigenic Variability of the Influenza Virus Nucleoprotein Despite Evolutionary Conservation.

Alexandra Rak, Veronika Muzurova, Svetlana Donina, Polina Prokopenko, Irina Isakova-Sivak, Larisa Rudenko

Abstract read
In one paragraph

Article in Antibodies (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandra RakInstitute of Experimental Medicine, 12 Acad. Pavlov Street, Saint-Petersburg 197022, Russia.ORCID 0000-0001-5552-9874
Veronika MuzurovaInstitute of Experimental Medicine, 12 Acad. Pavlov Street, Saint-Petersburg 197022, Russia.
Svetlana DoninaInstitute of Experimental Medicine, 12 Acad. Pavlov Street, Saint-Petersburg 197022, Russia.
Polina ProkopenkoInstitute of Experimental Medicine, 12 Acad. Pavlov Street, Saint-Petersburg 197022, Russia.
Irina Isakova-SivakInstitute of Experimental Medicine, 12 Acad. Pavlov Street, Saint-Petersburg 197022, Russia.
Larisa RudenkoInstitute of Experimental Medicine, 12 Acad. Pavlov Street, Saint-Petersburg 197022, Russia.ORCID 0000-0002-0107-9959

Funding

Russian Ministry of Science and Higher Education FGWG-2025-0015
6 · The paper itself

Abstract

backgroundThe highly mutable influenza virus causes severe annual infections worldwide and results in substantial socioeconomic losses. The spread of infection could be effectively controlled by cross-protective vaccines and universal diagnostic test systems based on the nucleoprotein (NP) as one of the most conserved viral antigens. However, NP also undergoes slow evolutionary changes, and little is known about the influence of these mutations on its antigenicity and immunogenicity.

methodsWe expressed the full-length recombinant 6xHis-tagged NPs of ten evolutionary distant influenza A strains of different subtypes in

resultsA pronounced cross-reactivity of anti-NP antibodies induced in mice by immunization with different NPs was revealed. At the same time, we observed the differences in the humoral immunogenicity of NP, which are in line with the accumulation of evolutionarily driven NP mutations. In general, antibody affinity to heterologous NPs was reduced, indicating the differences in the specificity of anti-NP immunoglobulins, which may be caused by evolutionarily determined variability of immunogenic epitopes leading to the emergence of escape mutations.

conclusionsOverall, our results reflect the slightly evolving nature of the NP antigen, which influences the specificity spectrum of anti-NP antibodies and should be considered as a limitation for the development of NP-based cross-protective vaccines and test systems.

Indexed as

antiviral antibodiescross-reactivityhumoral immunityimmunogenicityinfluenza virusnucleoprotein

Identifiers

PMID42200832
PMCPMC13214484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.